[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"HemoCept Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":57},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100610232",false,"NCT07224906","Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization","Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart","Inclusion Criteria:\n\n* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.\n* Subjects can be any gender but must be age 18 or older.\n* Subject is able and willing to provide informed consent and HIPAA authorization.\n* Subject is able and willing to meet all study requirements.\n* Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)\n\nExclusion Criteria:\n\n* Subject is pregnant, breastfeeding, or intends to become pregnant during this study.","ALL","18 Years",{"count":18,"type":19},50,"ESTIMATED","OBSERVATIONAL","The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.",[23,24,25],"Pulmonary Hypertension","Congestive Heart Failure(CHF)","Valve Disease, Heart","RECRUITING","2026-04-09",{"date":29,"type":30},"2026-04-13","ACTUAL",{"date":32,"type":30},"2025-12-01",{"date":34,"type":19},"2027-01",{"name":36,"class":37},"HemoCept Inc.","INDUSTRY",1,{"id":40,"slug":4,"hasResults":10,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":45,"enrollmentInfo":46,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":48,"conditions":49,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":51,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":56,"locationsCount":38},"100608729","NCT07205341","Detecting Changes in Arterial Blood Volume and Cardiac Efficiency","A Pilot Clinical Study to Assess Correlation Between Arterial Blood Volume Status and Cardiac Efficiency, and HemoCept Device Data in Trans-Aortic Valve Replacement (TAVR} Surgery","Inclusion Criteria:\n\n* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.\n* Subjects can be any gender but must be between (and including) the ages of 18 and 80.\n* Subject ls being treated by the participating healthcare facility .\n\n  ., Subject requires a trans-aortic valve replacement.\n* Subject is able and willing to provide informed consent and HIPM authorization.\n* Subject is able and willing to meet all study requirements.\n\nExclusion Criteria:\n\n* Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.\n* Subject has a personal medical history that includes:\n\n  * Long O-T syndrome\n  * Cardiac channelopathies\n  * Seizures","80 Years",{"count":47,"type":19},20,"The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.",[50],"Aortic Valve Stenosis",{"date":29,"type":30},{"date":53,"type":30},"2025-04-29",{"date":55,"type":19},"2026-09",{"name":36,"class":37},""]